35 research outputs found

    Raw data: Leaching ratio (μg/g) of mercury from Tibetan medicine Zuotai,β-HgS and α-HgS in different pH solutions

    No full text
    <p><i>Zuotai</i>, a known Tibetan medicinal mixture containing insoluble cubic mercuric sulfide (β-HgS), has been used to treat diseases with long history. The mercury leaching ratio from <i>Zuotai </i>in gastrointestinal pH environment is one determinant factor for its bioavailability and biological effect. However, the information is still scarce now. Therefore, the study was designed to investigate the mercury leaching from <i>Zuotai</i>, β-HgS, and α-HgS in different pH solutions</p><p>Solutions with different pH values (1–13) were prepared from pure water, HCl solution, and NaOH solution; the pH was monitored using a pH meter. The solutions were as follows: HCl solution with pH = 1, HCl solution with pH = 3, HCl solution with pH = 5, NaOH solution with pH = 7, NaOH solution with pH = 9, NaOH solution with pH = 11, and NaOH solution with pH = 13. A solid-liquid ratio of 1:100 was adopted in all leaching experiments. Digestion, peristalsis and emptying of drug in the gastrointestinal tract were simulated <i>in vitro</i>. We detected the mercury released in solutions using Automatic Direct Mercury Analyzer. Leaching Ratio of Mercury (μg/g)=[Total Weight of Mercury Released (μg)]/[Total Weight of Substance Tested (g)]</p><p>The results showed that the mercury leaching ratios of <i>Zuotai </i>at pH 1 and pH 13 were significantly higher than those at each point within pH 3–11; the mercury leaching ratio of <i>Zuotai</i> at pH 1 was higher than that at pH 13. The mercury leaching ratio of β-HgS slightly decreased from pH 1 to pH 3 and significantly increased from pH 3 to pH 13. The mercury leaching ratio of β-HgS at pH 13 was far higher than that at pH 1. For α-HgS, the mercury leaching ratio also slightly decreased from pH 1 to pH 3 and then gradually increased from pH 3 to pH 13. The mercury leaching ratio of α-HgS at pH 1 was lower than that at pH 13.</p><p> </p><p>Taken together, strong acidic or strong alkaline environments would promote the dissociation of mercury from <i>Zuotai</i>, β-HgS, and α-HgS.</p

    Raw data: Mercury leaching ratio (μg/g) from Tibetan medicine Zuotai,β-HgS and α-HgS in pure water and artificial gastrointestinal juices containing Cys(or GSH) or not.

    No full text
    <p><i>Zuotai</i>, a known Tibetan medicinal mixture containing insoluble cubic mercuric sulfide (β-HgS), has been used to treat diseases with long history. The mercury leaching ratio from <i>Zuotai </i>in gastrointestinal environment is one determinant factor for its bioavailability and biological effect. However, the information is still scarce now. Therefore, the study was designed to investigate the effect of sulfhydryl biomolecules [L-cysteine (Cys) and glutathione (GSH)] on mercury leaching from <i>Zuotai</i>, β-HgS, and α-HgS in artificial gastrointestinal juices or pure water.</p> <p>The artificial gastric juice and artificial intestinal juice were prepared according to the methods described in <i>Chinese Pharmacopoeia </i>(2010 version). The following solutions were prepared: Cys in pure water (5.21 g/L), GSH in pure water (13.21 g/L), Cys in artificial gastric juice (5.21 g/L), GSH in artificial gastric juice (13.21 g/L), Cys in artificial intestinal juice (5.21 g/L), and GSH in artificial intestinal juice (13.21 g/L). The moles of Cys and GSH in this study were 0.215 mmol—the same as that of β-HgS and α-HgS. A solid-liquid ratio of 1:100 was adopted in all leaching experiments. Digestion, peristalsis and emptying of drug in the gastrointestinal tract were simulated <i>in vitro</i>. We detected the mercury released in solutions using Automatic Direct Mercury Analyzer. Leaching Ratio of Mercury (μg/g)=[Total Weight of Mercury Released (μg)]/[Total Weight of Substance Tested (g)]</p> <p>The results showed the following trend for the mercury leaching ratio of<i> Zuotai</i>: artificial gastric juice > artificial intestinal juice > pure water, whereas the trend for β-HgS and α-HgS was as follows: artificial intestinal fluid > artificial gastric fluid > pure water. The mercury leaching ratios of <i>Zuota</i>i, β-HgS, and α-HgS significantly increased in artificial intestinal juice containing L-Cys or GSH compared to that without sulfhydryl biomolecules in the juice. However, in pure water and artificial gastric juice with Cys or GSH, the mercury leaching ratio of <i>Zuotai </i>reduced remarkably, in contrast to the results observed for β-HgS and α-HgS.</p><div><p></p></div

    Coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma Cells-0

    No full text
    <p><b>Copyright information:</b></p><p>Taken from "Coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma Cells"</p><p>http://www.biomedcentral.com/1471-2407/7/208</p><p>BMC Cancer 2007;7():208-208.</p><p>Published online 12 Nov 2007</p><p>PMCID:PMC2186345.</p><p></p> assay. (B) SMMC-7721 cells were incubated with (b,d) or without (a,c) 5-Fu (62.5 μg/ml) for 36 h were stained by the TUNEL method to reveal DNA strand breaks indicative of apoptosis. (a) (b) bright field micrographs corresponding to (c) and (d), respectively. (c)(d), micrographs taken with fluorescent microscopy (400×)

    Strategie firmy

    No full text
    Import 20/04/2006Prezenční výpůjčkaVŠB - Technická univerzita Ostrava. Ekonomická fakulta. Katedra (115) podnikatelství a management

    Immunohistochemical staining of TGF-β, HIF-1α, VEGF and pERK 1/2 expression in gastric cancer.

    No full text
    <p>A. Immunohistochemical staining of TGF-β was located mainly in the cytoplasm of tumor cells (positive expression ×400); B. TGF-β original magnification ×100; C. HIF-1α was located mainly in the nucleus of tumor cells (positive expression ×400); D. HIF-1α original magnification ×100; E. VEGF was located mainly in the cytoplasm of tumor cells (positive expression ×400); F. VEGF original magnification×100; G. pERK1/2 was located in the cytoplasm and nucleus of tumor cells (positive expression ×400); H. pERK1/2 original magnification ×100.</p

    Kaplan-Meier curves for overall survival.

    No full text
    <p>TGF-β, HIF-1α, VEGF and pERK 1/2 overexpression were divided into an overexpression group and a weak-expression group. A log-rank test was used to calculate significance. A. Overall survival curves stratified by TGF-β expression (<i>P</i> = 0.139). B. Overall survival curves stratified by HIF-1α expression (<i>P</i> = 0.000). C. Overall survival curves stratified by VEGF expression (<i>P</i> = 0.217). D. Overall survival curves stratified by pERK 1/2 expression (<i>P</i> = 0.018).</p

    Multivariate analysis of significant prognostic factors for survival in patients with gastric carcinoma.

    No full text
    <p>DFS, Disease-free survival; OS, Overall Survival; HR, hazard ratio; CI, Confidence interval; *P<0.05; 1, A, Adenocarcinoma, S, Absolute signet ring cell carcinoma, M, Mixed carcinoma; 2, I, Intestinal, D, Diffuse, M, Mixed type; 3, P/D, Poor differentiation, M/D, Moderate differentiation, H/D High differentiation; 4, W, Weak-expression, O, Overexpression.</p

    Discovery of a New Series of Naphthamides as Potent VEGFR‑2 Kinase Inhibitors

    No full text
    Inhibition of VEGFR-2 signaling pathway has already become one of the most promising approaches for the treatment of cancer. In this study, we describe the design, synthesis, and biological evaluation of a new series of naphthamides as potent inhibitors of VEGFR-2. Among these compounds, <b>14c</b> exhibited high VEGFR-2 inhibitory potency in both enzymatic and HUVEC cellular proliferation assays, with IC<sub>50</sub> values of 1.5 and 0.9 nM, respectively. Kinase selectivity profiling revealed that <b>14c</b> was a multitargeted inhibitor, and it also exhibited good potency against VEGFR-1, PDGFR-β, and RET. Furthermore, <b>14c</b> effectively blocked tube formation of HUVEC at nanomolar level. Overall, <b>14c</b> might be a promising candidate for the treatment of cancer
    corecore